Redeye updates its estimates and valuation following Vitec releasing its Q1 2023 report. We judge that notable positives from the report include continued strong sales growth and solid margins. We adjust our M&A estimates and valuation following the company’s Q1 report and Enova acquisition.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/